Fresenius Medical Care (FME) Refines China Strategy; To Take ~€110M One-Time Charge

Fresenius Medical Care will exit its China peritoneal dialysis business and discontinue local 4008A sales, focusing on advanced in-center dialysis and critical care. It expects ~€110M one-time costs in Q3 2026, treated as a special item.Material DetailsContext by AI AnalystThis is a mid-cycle portf…